Migraine
Not recruitingStudy on Lasmiditan for Treating Migraine in Children Aged 6 to 17
- Disease:Migraine
- Substances:Lasmiditan
France- Participants:0–17 years
- Substances:Lasmiditan
- Sponsor:Eli Lilly & Co.
Rare diseases
Investigational molecules
Locations
Back to France45 clinical trials in Mont-de-Marsan, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
France
France
France
France
France
France
France
France
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple myeloma and lymphoma treatments, evaluating novel therapeutic combinations and transplant alternatives.
Several trials are investigating immunotherapy combinations and targeted treatments for better patient outcomes.
Comprehensive studies examining treatments for lung cancer, breast cancer, and prostate cancer, with emphasis on immunotherapy approaches.
Investigations focus on improving survival rates through targeted and combination therapies.
Research into migraine treatments, particularly focusing on pediatric populations and new therapeutic approaches.
Trials aim to establish safe and effective treatments for younger patients with migraine.
Tell us about your condition – we search every trial in Europe and connect you with the right site.